Analysis of the function of lymphocyte adhesion molecules and its clinical significances in autoimmune diseases
Analysis of the function of lymphocyte adhesion molecules and its clinical significances in autoimmune diseases
批准号:
13470107
负责人:
MORIMOTO Chikao
金额:
$10.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
b1整合素和配体的表达在类风湿关节炎(RA)的炎性病变中升高,crk相关底物淋巴细胞型(Cas-L)是一种对接蛋白,通过T细胞中β1整合素的参与,酪氨酸磷酸化程度很高。在本研究中,我们试图评估Cas-L在类风湿关节炎(RA)病理生理中的作用。我们分析了人类嗜t淋巴病毒I型(HTLV-I)转基因小鼠,因为它们发生类似于人类RA的多发性关节炎。本研究表明,有关节炎的转基因小鼠(Atg)脾脏细胞的迁移活性远高于无关节炎的转基因小鼠(Ntg)和同窝对照小鼠(Ct)。生化研究发现,Atg小鼠与Ntg和Ct小鼠相比,Cas-L蛋白及其自发酪氨酸磷酸化增加,这可能是由激活的fyn和lck引起的。免疫组化分析显示大量casl阳性淋巴细胞迁移到病变关节。最后,在人类风湿性关节炎中,casl阳性淋巴细胞已被证明浸润到炎性病变。以上结果强烈提示Cas-L可能在RA的病理生理中起重要作用。
英文摘要
It has been repeated that the expression of b1 integrins and ligands are elevated in the inflammatory lesions in rheumatoid arthritis (RA), Crk-associated substrate lymphocyte type (Cas-L) is a docking protein that is heavily tyrosine phosphorylated by the engagement of β1 integrins in T cells.In the present study, we attempted to evaluate the role of Cas-L in the pathophysiology of rheumatoid arthritis (RA). We analyzed human T-lymphotropic virus type I (HTLV-I) tax transgenic mice, since they develop polyarthritis resembling human RA. Here we show that migratory activity of spleen cells from tax transgenic mice with arthritis (Atg) was much higher than that of tax transgenic mice without arthritis (Ntg) and littermate control mice (Ct). Biochemical studies revealed that Cas-L protein and its spontaneous tyrosine phosphorylation were increased in Atg mice compared to Ntg and Ct mice, which might be caused by activated fyn and lck. Immunohistochemical analysis showed a large number of Cas-L positive lymphocytes migrating into the affected joints. Finally, in human RA, Cas-L positive lymphocytes have been shown to infiltrate to the inflammatory lesions. The above results strongly suggest that Cas-L appears to play an important role in the pathophysiology of RA.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ouchida R, Kusuhara M, Shimizu N, Hisada T, Makino Y, Morimoto C, Handa H, Ohsuzu F, Tanaka H: "Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells"
Ouchida R、Kusuhara M、Shimizu N、Hisada T、Makino Y、Morimoto C、Handa H、Ohsuzu F、Tanaka H:“六亚甲基双乙酰胺诱导蛋白 HEXIM1 在人血管平滑肌中抑制 NF-kappaB 依赖性基因表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki T, Nakamoto T, Ogawa S, Seo S, Matsumura T, Tachibana K, Morimoto C, Hirai H: "MICAL, a novel CasL interacting molecule, associates with vimentin"J Biol Chem. 277. 14933-14941 (2002)
Suzuki T、Nakamoto T、Okawa S、Seo S、Matsumura T、Tachibana K、Morimoto C、Hirai H:“MICAL,一种新型 CasL 相互作用分子,与波形蛋白结合”J Biol Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
lwata S: "Distinctive signaling pathways through CD82 and β1 integrins in human T cells"Eur.J.Immunol. 32. 1328-1337 (2002)
Iwata S:“人 T 细胞中通过 CD82 和 β1 整合素的独特信号传导途径”Eur.J.Immunol. 32. 1328-1337 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hisakawa N, Tanaka H, Hosono O, Nishijima R, Ohashi Y, Saito S, Nishiya K, Hashimoto K, Morimoto C.: "Aberrant Responsiveness to RANTES in Synovial Fluid T cells ten Patients with Rheumatoid Arthritis"J. Rheumatol.. 29. 1124-1134 (2002)
Hisakawa N、Tanaka H、Hosono O、Nishijima R、Ohashi Y、Saito S、Nishiya K、Hashimoto K、Morimoto C.:“十名类风湿关节炎患者滑液 T 细胞对 RANTES 的异常反应”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hase H, Kanno Y, Kojima H, Morimoto C, Okumura K, Kobala T: "CD27 and CD40 inhibit p53-independent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligation"J Biol Chem. 277. 46950-46958 (2002)
Hase H、Kanno Y、Kojima H、Morimoto C、Okumura K、Kobala T:“CD27 和 CD40 在 B 细胞受体连接诱导的 B 细胞凋亡中抑制 p53 独立的线粒体途径”J Biol Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
-
批准号:24659401
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2012
-
负责人:MORIMOTO Chikao
-
依托单位:
To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
-
批准号:22650223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.12万
-
财政年份:2010
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
-
批准号:22390200
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
-
批准号:17109011
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$71.72万
-
财政年份:2005
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic study of molecular target therapy for autoimmune diseases and immune deficiency diseases based on CD26
-
批准号:15209033
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.79万
-
财政年份:2003
-
负责人:MORIMOTO Chikao
-
依托单位:
The development of specific immune regulatory drugs utilizing the structure and function of CD26
-
批准号:13557039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.75万
-
财政年份:2001
-
负责人:MORIMOTO Chikao
-
依托单位:
Analysis of CD29/VLA integrin in T cell immune regulation and its clinical significance
-
批准号:11307009
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$23.42万
-
财政年份:1999
-
负责人:MORIMOTO Chikao
-
依托单位:
Structure and function of memory T cell marker CD26
-
批准号:11694248
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$2.56万
-
财政年份:1999
-
负责人:MORIMOTO Chikao
-
依托单位:
Development of specific imuune regulatoly drugs by the cell surface molecules.
-
批准号:10557049
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.06万
-
财政年份:1998
-
负责人:MORIMOTO Chikao
-
依托单位:
Analysis of CD26 mediated signal transduction mechanism.
-
批准号:09044266
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.56万
-
财政年份:1997
-
负责人:MORIMOTO Chikao
-
依托单位:
Determination of molecular basis of immunoregulation of human T cell circuit and its clinical significances
-
批准号:09307009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$21.57万
-
财政年份:1997
-
负责人:MORIMOTO Chikao
-
依托单位:
Development of immunoregulatory therapy via CD26 activation pathway.
-
批准号:08557036
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$10.18万
-
财政年份:1996
-
负责人:MORIMOTO Chikao
-
依托单位:
海外基金